August 11, 2010
The European Medicines Agency (EMA) and the Food and Drug Administration of the United States of America (US FDA) continue to seek potential candidate companies for a joint GMP inspection pilot programme for manufacturers of medicinal products.

July 23, 2010
Meeting highlights are available from the Committee for Medicinal Products for Human Use (CHMP) 19-22 July 2010.

July 23, 2010
The European Medicines Agency concludes its review of modified-release oral opioids of the WHO level III scale for the management of pain.

July 22, 2010
The European Medicines Agency has issued an update on the ongoing benefit-risk review of Avandia, Avandamet and Avaglim.

July 22, 2010
The European Medicines Agency confirms the positive benefit-risk balance of Rotarix.

July 22, 2010
The European Medicines Agency confirms the positive benefit-risk balance of topical formulations of ketoprofen.

July 20, 2010
A new policy on communicating safety-related issues on medicines for human use has been published by the European Medicines Agency (EMA).